Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level
Crossref DOI link: https://doi.org/10.1007/s10549-016-3940-7
Published Online: 2016-08-12
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Verschoor, A. M. F.
Kuijer, A.
Verloop, J.
Van Gils, C. H.
Sonke, G. S.
Jager, A.
van Dalen, T.
Elias, S. G. http://orcid.org/0000-0002-6666-1368
License valid from 2016-08-12